It is not uncommon for patients to be switched from one antipsychotic to another. Chlorpromazine equivalents help guide clinicians in estimating an approximately equivalent dose when transitioning from one antipsychotic to another.

How should I convert doses between different antipsychotics?1-7

What resources are available for identifying kinetic information of various antipsychotic medications?

Antipsychotic Dose Equivalents (based on chlorpromazine)

Generic Brand Dose Equivalent
First Generation Antipsychotics
Chlorpromazine Thorazine© 100 mg
Fluphenazine Prolixin© 2 mg
Haloperidol Haldol© 2 mg
Loxapine Loxitane© 10 mg
Perphenazine Trilafon© 8 mg
Pimozide Orap© 2 mg
Prochlorperazine Compazine© 15 mg
Trifluoperazine Stelazine© 2-5 mg
Thioridazine Mellaril© 100 mg
Thiothixene Navane© 4 mg
Second Generation Antipsychotics
Aripiprazole Abilify© 7.5 mg
Asenapine Saphris© 4 mg1
Brexpiprazole Rexulti© N/A
Cariprazine Vraylar© N/A
Clozapine Clozaril© 100 mg
Iloperidone Fanapt© 3-4 mg1
Lurasidone Latuda© 16 mg1
Lumateperone Caplyta© Unknown
Olanzapine Zyprexa© 5 mg
Paliperidone Invega© 2 mg1
Quetiapine Seroquel© 75 mg
Risperidone Risperdal© 1 mg
Ziprasidone Geodon© 60 mg

Reviewer 1: Katy Zeier, PharmD, BCPP
Reviewer 2: Megan Sarashinsky, PharmD, BCPP
Reviewer 3: Austin Smith, PharmD, BCPP
2023-2024 AAPP Resident and New Practitioner Committee


  1. Leucht S, Samara M, Heres S, Patel MX, Woods SW, Davis JM. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophrenia Bulletin. 2014;40(2):314-26. DOI: 10.1093/schbul/sbu001. PubMed PMID: 24493852; PubMed Central PMCID: PMC3932104.
  2. Leucht S, Samara M, Heres S, et al. Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr Bull. 2015;41(6):1397-402.  [PubMed]
  3. Patel MX, Arista IA, Taylor M, Barnes TRE. How to compare doses of different antipsychotics: a systematic review of methods. Schizophr Res. 2013;149(1-3):141-8. DOI: 10.1016/j.schres.2013.06.030. PubMed PMID: 23845387.
  4. Rothe PH, Heres S, Leucht S. Dose equivalents for second generation long-acting injectable antipsychotics: The minimum effective dose method. Schizophrenia Res. 2018;193:23-28. DOI: 10.1016/j.schres.2017.07.033. PubMed PMID: 28735640.
  5. Taylor D,. Barnes T, Young A. The Maudsley Prescribing Guidelines in Psychiatry, Wiley-Blackwell. 14th Edition, 2021.
  6. Schatzberg AF, and DeBattista C. Manual of Clinical Psychopharmacology, American Psychiatric Publishing;  9th Edition, 2019.
  7. Woods SW. Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics. J. Clin. Psychiatry. 2003;64(6):663- 667. DOI: 10.4088/JCP.v64n0607. PubMed PMID: 12823080.
  8. Siafis S, Tzachanis D, Samara M, and Papazisis G. Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr Neuropharmacol. 2018;16(8)1210-1223. [PubMed]
  9. Skalad SR. Graphic representation of pharmacology: Development of an alternative model. Ment Health Clin. 2017 Sep; 7(5): 201-206. [Pubmed]
  10. PDSP Ki Database: BL Roth, WK Kroeze, S Patel and E Lopez. The Multiplicity of Serotonin Receptors: Uselessly diverse molecules or an embarrasment of riches? The Neuroscientist. 2000;6:252-262. [Weblink]
  11. Kusumi I, Boku S, Takahashi, Y. Psychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesis. Psychiatry Clin Neurosci. 2015;69(5):243-58. [Pubmed]